Digest Network Come funziona
Network
/
Società
Co
Non verificato

Cognito Therapeutics

Di cosa scriviamo

IndustriaMedicina - VarieSaluteScienzaVetrine/Shopping

23 comunicati stampa

Guarda tutti i comunicati
08/04/2026
Multimedialità
Volontariato/Solidarietà/Non profit
Software
Scienza
Hardware informatico
Farmaceutica
Information Technology
Vetrine/Shopping
Tecnica
Attrezzature medico-sanitarie
Medicina - Varie
Biotecnologia
Terza età
Salute
Cognito Therapeutics Partners with Initiative to Change the “D-Word,” Commits to Eliminating Use of “Dementia” Across All Communications
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0
25/03/2026
Cognito Therapeutics and Ochsner Health Launch Brain Health Collaboratory to Advance New Care Models for Alzheimer’s Disease
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0
17/03/2026
Cognito Therapeutics Presents New Data on Spectris™ in Alzheimer’s Disease at AD/PD™ 2026
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0
11/03/2026
Cognito Therapeutics Appoints Thomas Fagan as Executive Vice President, Alzheimer’s Portfolio
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0
05/03/2026
Cognito Therapeutics Announces Oversubscribed $105 Million Series C Financing to Advance Spectris™ in Alzheimer’s Disease
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0
03/12/2025
Cognito Therapeutics Announces Presentation of New CSF Proteomic and EEG Biomarker Data for Spectris™ in Alzheimer’s Disease at CTAD 2025
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0
18/11/2025
Software
Scienza
Hardware informatico
Vetrine/Shopping
Tecnica
Attrezzature medico-sanitarie
Medicina - Varie
Biotecnologia
Terza età
Salute
Eventi
Industria
Cognito Therapeutics to Present New Biomarker Data for Spectris™ in Alzheimer’s Disease at CTAD 2025
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0
13/11/2025
WVU Rockefeller Neuroscience Institute and Cognito Therapeutics Launch Brain Health Collaboratory to Accelerate Neurotherapies with AI-powered Research
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0
28/07/2025
Cognito Therapeutics Presents Clinical Trial Data Highlighting Neuroprotective Potential of Spectris™ in Alzheimer’s Disease at AAIC 2025
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0
17/07/2025
Eventi
Industria
Terza età
Biotecnologia
Salute
Attrezzature medico-sanitarie
Vetrine/Shopping
Medicina - Varie
Cognito Therapeutics to Present Five Abstracts at AAIC 2025 Highlighting Spectris™ Treatment in Alzheimer’s Disease
Fonte
Cognito Therapeutics
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0